Patent · US Active

CD131 binding proteins

US10894834B2 · kind B2 · utility

1Cited by

0References

5Claims

0Family size

Assignee

CSL LIMITED · AU

Inventors

Catherine OWCZAREK · Melbourne, AU
Kosta PANOUSIS · Melbourne, AU
Nicholas Stuart Wilson · Melbourne, AU
Matthew HARDY · Whittlesea, AU
Kirsten Mae Edwards · Melbourne, AU
Veronika Rayzman · Melbourne, AU

Key dates

Filing date	Nov 25, 2016
Grant date	Jan 19, 2021
Priority date	—
Expiry date	May 28, 2037

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/70596
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides a CD131-binding protein comprising an antigen binding domain of an antibody, wherein the antigen binding domain binds to or specifically binds to CD131 and neutralizes signaling by interleukin (IL) 3, IL-5 and granulocyte-macrophage colony stimulating factor (GM-CSF), and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.